Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Aug;95(8):3955-64.
doi: 10.1210/jc.2010-0102. Epub 2010 Jun 9.

The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men

Kishore M Lakshman  1 , Beth Kaplan, Thomas G Travison, Shehzad Basaria, Philip E Knapp, Atam B Singh, Michael P LaValley, Norman A Mazer, Shalender Bhasin
Affiliations
Randomized Controlled Trial

The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men

Kishore M Lakshman et al. J Clin Endocrinol Metab. 2010 Aug.

Abstract

Background: During testosterone (T) therapy, T is partly converted to 17beta-estradiol (E2) and 5alpha-dihydrotestosterone (DHT). Effects of age, testosterone dose, and body composition on total and free E2 and DHT levels are unknown.

Objective: We evaluated age and dose-related differences in E2 and DHT levels in response to graded doses of testosterone enanthate in young and older men.

Methods: Fifty-one young (aged 19-35 yr) and 52 older (aged 59-75 yr) men completed treatment with monthly injections of a GnRH agonist plus randomly assigned weekly doses of testosterone enanthate (25, 50, 125, 300, or 600 mg) for 5 months.

Results: During testosterone administration, total and free E2 levels increased dose-dependently (dose effect, P<0.001) in both young and older men. Total and free E2 levels and E2:T ratios during T administration were higher in older than young men, but age-related differences in free E2 and free E2:T ratios were not significant after adjusting for testosterone levels, percentage fat mass, and SHBG. DHT levels and DHT:T ratios were dose-related but did not differ between young and older men. Mechanistic modeling of free hormone data revealed that the conversions of T to E2 and DHT were both consistent with saturable Michaelis-Menten kinetics. The in vivo Km values were estimated to be 1.83 nm for aromatase and 3.35 nm for 5alpha-reductase, independent of age. The Vmax parameter for E2 was 40% higher in older men than younger men, but Vmax for DHT was not significantly different between age groups.

Conclusions: During im testosterone administration, E2 and DHT levels exhibit saturable increases with dose. The rate of whole body aromatization is higher in older men, partly related to their higher percentage fat mass, SHBG, and testosterone levels.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Serum E2, DHT, E2:T ratios, and DHT:T ratios in response to administration of graded doses of TE in young (black bars) and older men (white bars). If there was a significant age effect, the values for young and older men for each dose were compared using t tests. The asterisk indicates significant differences between young and older men receiving that dose (P < 0.05). A, A dose-dependent increase in serum total E2 (left) and free E2 (right) levels with a significant age and dose effect. B, A dose-dependent increase in serum total DHT (left) and free DHT (right) levels with a significant dose effect only. C, A dose-dependent decrease in total E2:total T (left) and free E2:free T (right) ratios with a significant age and dose effect. D, A dose-dependent decrease in serum total DHT:total T (left) and free DHT:free T ratios (right) with a significant dose effect only. To convert total testosterone to nanomoles per liter, multiply by 0.03467; to convert free testosterone to picomoles per liter, multiply by 3.467. To convert estradiol concentrations to picomoles per liter, multiply by 3.671. To convert total DHT to nanomoles per liter, multiply by 0.0344; to convert free DHT to picomoles per liter, multiply by 3.44.
Figure 2
Figure 2
The relationship of total E2 and total DHT to total testosterone (TT) concentrations at baseline (symbol X) or during treatment (Tx; symbol ○) with graded doses of testosterone in young men (A and C) and older men (C and D). Dashed lines are derived from fitting all data points to a Michaelis-Menten (MM) mechanistic model (see Appendix A for details).
Figure 3
Figure 3
The relationship of free E2 (FE2) and free DHT (FDHT) to free testosterone (FT) concentrations at baseline (symbol X) or during treatment (Tx; symbol ○) with graded doses of testosterone in young men (A and C) and older men (C and D). Dashed lines are derived from fitting all data points to a Michaelis-Menten (MM) mechanistic model (see Appendix A for details).
See this image and copyright information in PMC

References

    1. Simpson ER 2003 Sources of estrogen and their importance. J Steroid Biochem Mol Biol 86:225–230 - PubMed
    1. Longcope C, Kato T, Horton R 1969 Conversion of blood androgens to estrogens in normal adult men and women. J Clin Invest 48:2191–2201 - PMC - PubMed
    1. Meikle AW, Mazer NA, Moellmer JF, Stringham JD, Tolman KG, Sanders SW, Odell WD 1992 Enhanced transdermal delivery of testosterone across nonscrotal skin produces physiological concentrations of testosterone and its metabolites in hypogonadal men. J Clin Endocrinol Metab 74:623–628 - PubMed
    1. Schubert M, Minnemann T, Hübler D, Rouskova D, Christoph A, Oettel M, Ernst M, Mellinger U, Krone W, Jockenhövel F 2004 Intramuscular testosterone undecanoate: pharmacokinetic aspects of a novel testosterone formulation during long-term treatment of men with hypogonadism. J Clin Endocrinol Metab 89:5429–5434 - PubMed
    1. von Eckardstein S, Nieschlag E 2002 Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study. J Androl 23:419–425 - PubMed

Publication types